Uri Lopatin is the founder of Ukko. Ukko has raised $85M in total funding. Latest round: Series B. Backed by Leaps by Bayer. Based in Mountain View, CA.
Uri Lopatin, MD is the Co-founder and Chief Executive Officer of Ukko, a biotechnology company focused on eliminating food allergies and sensitivities through precision treatments. He previously served as an Operating Partner at Khosla Ventures starting in 2023. Lopatin led Ukko through regulatory clearance to advance its lead program UKK-0018 for peanut anaphylaxis into clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library